Development and marketing of biopharmaceutical products in the field of pulmonary diseases, such as lung cancer. The company may also undertake, on its own account or on behalf of third parties, any other industrial, commercial, financial, movable or immovable operations, directly or indirectly related to its purpose, excluding operations subject to authorization under the Federal Act on the Acquisition of Real Estate by Foreigners (LFAIE). It may open branches in Switzerland or abroad and may also acquire participations in other companies. It may grant loans or provide other financing to its direct or indirect associates as well as to other group companies. It may provide guarantees of all kinds for the obligations of these companies, such as pledges or other fiduciary transfers of the company's assets or guarantees of all kinds, against payment or free of charge. It may also enter into centralized treasury management agreements (cash pooling) with other group companies.